KEYTRUDA β MERCK SHARP DOHME, approved 2026-07-10 (BLA125514).
63,332 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System β they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.